Zobrazeno 1 - 10
of 18
pro vyhledávání: '"O. M. Votyakova"'
Publikováno v:
Онкогематология, Vol 0, Iss 4, Pp 11-16 (2022)
Treatment results in a group of patients with multiple myeloma (n=18) treated with melfalan (200 mg/m2) followed by autologous peripheral blood stem cell transplantation as a second-line therapy are presented. Thirteen patients received one course of
Externí odkaz:
https://doaj.org/article/c64ef0ba59af417a864c050ffaaa530e
Autor:
A. A. Solodovnik, H. S. Mkrtchyan, V. A. Misyurin, V. V. Tikhonova, Yu. P. Finashutina, N. N. Kasatkina, O. N. Solopova, O. M. Votyakova, O. Yu. Yakimovich, O. M. Volodina, M. Yu. Kichigina, E. G. Medvedovskaya, A. S. Antipova, I. Z. Zavodnova, A. A. Semenova, G. R. Arakelyan, Yu. E. Ryabukhina, O. A. Kolomeytsev, A. D. Shirin, E. A. Osmanov, A. V. Misyurin
Publikováno v:
Успехи молекулярной онкологии, Vol 5, Iss 2, Pp 62-70 (2018)
Objective: to study the prognostic significance of the expression of cancer-testis (CT) genes PRAME, NY-ESO1, GAGE1, MAGE A3, MAGE A6, MAGE A12, SSX1, SLLP1, PASD1 in patients with multiple myeloma (MM) and their influence on overall survival and rel
Externí odkaz:
https://doaj.org/article/b0aa8abe11aa425e8a24ca45472d22ad
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 45, Iss 2, Pp 102-108 (2017)
Background: Analysis of free light chains of immunoglobulins (FLC) in the serum is an effective method in the diagnosis of multiple myeloma. Plasma cells produce two types of FLC: κand λ-FLC. FLC, which are not incorporated into monoclonal intact i
Externí odkaz:
https://doaj.org/article/17548276f8ab4aa8907330718865836c
Autor:
O. M. Votyakova
Publikováno v:
Бюллетень сибирской медицины, Vol 7, Iss 0, Pp 33-41 (2008)
Externí odkaz:
https://doaj.org/article/0ef93579d97444e396d38725e6363cc2
Autor:
Nina Vasilyevna Lyubimova, Yu. S. Timofeev, V. M. Abaev, O. M. Votyakova, E. A. Osmanov, N. E. Kushlinskii
Publikováno v:
Klinicheskaia laboratornaia diagnostika. 67(10)
Multiple myeloma (MM) is a malignant tumor occurring from plasma cells that produce an abnormal monoclonal immunoglobulin - a paraprotein. A distinctive feature of Bence-Jones myeloma is the excretion of monoclonal free light chains of immunoglobulin
Autor:
G. R. Arakelyan, O. Yu. Yakimovich, Yu. P. Finashutina, NN Kasatkina, A. S. Antipova, Yu. E. Ryabukhina, V. A. Misyurin, H. S. Mkrtchyan, A. A. Semenova, A D Shirin, M. Yu. Kichigina, IZ Zavodnova, A. A. Solodovnik, O. M. Votyakova, O. A. Kolomeytsev, V. V. Tikhonova, A. V. Misyurin, O. N. Solopova, EG Medvedovskaya, EA Osmanov, O. M. Volodina
Publikováno v:
Uspehi Molekulârnoj Onkologii, Vol 5, Iss 2, Pp 62-70 (2018)
Objective:to study the prognostic significance of the expression of cancer-testis (CT) genes PRAME, NY-ESO1, GAGE1, MAGE A3, MAGE A6, MAGE A12, SSX1, SLLP1, PASD1 in patients with multiple myeloma (MM) and their influence on overall survival and rela
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 9, Iss 3, Pp 296-301 (2016)
Aim. To analyze the relationship between expression of aberrant CD45, CD19, CD56 markers on the plasma cells and clinical and laboratory findings and prognostically significant parameters in patients with multiple myeloma (MM). Methods. This scientif
Autor:
O M Votyakova
Publikováno v:
Современная онкология, Vol 17, Iss 5, Pp 33-43 (2015)
Extramedullary plasmacytoma (EP) represents a rare category of malignant disease on which there are limited data in regard to diagnosis, staging and therapy. EP - where the clump of abnormal plasma cells occurs outside the bone in soft tissue. These
Autor:
Ryzhko Vv, T V Abramova, L A Grebenyuk, M V Solovyev, V G Savchenko, Elena O. Gribanova, M V Nareyko, M A Rusinov, T N Obukhova, O M Votyakova, Sergei M. Kulikov, L P Mendeleeva, Olga S. Pokrovskaya
Publikováno v:
Терапевтический архив, Vol 89, Iss 7, Pp 32-38 (2017)
To determine the prevalence of amp1q21 and its relationship to the clinical manifestations of multiple myeloma (MM).In December 2009 to March 2016, a total 134 patients aged 30 to 81 years (median 57 years) underwent a pretreatment FISH-study of bone
Publikováno v:
Bulletin of Experimental Biology and Medicine. 153:249-254
Serum concentrations of κ- and λ-free light chains and their ratios were compared in 126 patients with monoclonal gammapathies (age 23-80 years) and 60 normal subjects (25-82 years). The main group included patients with intact immunoglobulin multi